COTY vs REGN · rev $5.89B vs P/E 14, rev $14.34B
Coty Inc (COTY) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Coty Inc (COTY) is a household & personal products company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported COTY revenue for 2025-06-30 was $5.89B. Net income was -$350.2M. Revenue was down 3.7% from 2024-06-30 to 2025-06-30. COTY currently screens at market cap $1.73B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
COTY currently screens at market cap $1.73B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the COTY and REGN stock pages for the full models.
Not investment advice.